Stephen D. Miller

Jun. 07, 2013

Promising Results in Early Trial of Novel MS Treatment

A small, early clinical trial shows it may be feasible to alter the immune response that leads to MS.

ms, multiple sclerosis, brain, nervous system, drug treatment, autoimmune disease, Science Translational Medicine, Stephen D. Miller

AVAILABLE IN ITUNES

Michael Pollan Talks Plants and Food

view more

FEATURED PLAYLIST

Microbiome Bonanza

BOOKS BY OUR GUESTS

Mystery Box

Can the Bacteria in Your Gut Send Messages to Your Brain?

Researchers discuss how the microbiome might play a role in anxiety, depression, and autism.

Science Friday® is produced by the Science Friday Initiative, a 501(c)(3) nonprofit organization.

Science Friday® and SciFri® are registered service marks of Science Friday, Inc. Site design by Pentagram; engineering by Mediapolis.

 

topics